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Lysine lactoylation is a recently described protein post-translational
modification (PTM). However, the biochemical pathways responsible for this
acylation remain unclear. Two metabolite-dependent mechanisms have been
proposed: enzymatic histone lysine lactoylationderived from lactoyl-coenzyme
A (lactoyl-CoA, also termed lactyl-CoA), and non-enzymatic lysine lactoylation
resulting from acyl-transfer via lactoyl-glutathione. While the former has
precedent in the form of enzyme-catalysed lysine acylation, the lactoyl-CoA
metabolite has not been previously quantified in mammalian systems.
Here, we use liquid chromatography–high-resolution mass spectrometry
(LC-HRMS) together with a synthetic standard to detect and validate the pres-
ence of lactoyl-CoA in cell and tissue samples. Conducting a retrospective
analysis of data from previously analysed samples revealed the presence of lac-
toyl-CoA in diverse cell and tissue contexts. In addition, we describe a
biosynthetic route to generate 13C3
15N1-isotopically labelled lactoyl-CoA, pro-
viding a co-eluting internal standard for analysis of this metabolite. We
estimate lactoyl-CoA concentrations of 1.14 × 10−8 pmol per cell in cell culture
and 0.0172 pmol mg−1 tissue wet weight in mouse heart. These levels are simi-
lar to crotonyl-CoA, but between 20 and 350 times lower than predominant
acyl-CoAs such as acetyl-, propionyl- and succinyl-CoA. Overall our studies
provide the first quantitative measurements of lactoyl-CoA in metazoans,
and provide a methodological foundation for the interrogation of this novel
metabolite in biology and disease.
1. Introduction
Acyl-coenzyme A (acyl-CoA) thioesters serve as critical metabolites in cellular
energy metabolism. They also play a role in cellular signalling, acting as the
acyl-donors for enzymatic and non-enzymatic PTMs collectively known as
lysine acylation. Several studies have found that lysine acylation is sensitive to
cellular metabolism, implying that acyl-CoA levels may directly link metabolism
to PTM-mediated signalling [1]. This has the potential to occur either via the
© 2020 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
utilization of acyl-CoAs as rate-limiting cofactors in enzymatic
protein modifications catalysed by lysine acyl-transferase
(KAT) and histone acyltransfease (HAT) enzymes, or through
non-enzymatic acylation reactions that can be heavily influ-
enced by the electrophilicity of individual acyl-CoA species
[2]. A physiochemically diverse set of acylations have been
detected on histone lysine residues, including not only the pre-
dominant acetylation but also succinylation, propionylation,
(iso)butyrylation, crotonylation, malonylation and several
others [3]. Lysine acylations generally correlate closely with
the abundance of corresponding acyl-CoA [4].
Recently, Zhang et al. [5] reported a new addition to this
emerging class of PTMs, known as lysine lactoylation. Apply-
ing antibody-based enrichment, this PTM was mapped to
histone in M1 polarized macrophages and shown to correlate
with altered gene expression during immune activation.
Furthermore, lysine lactoylation within in vitro transcription
assays was found to be dependent on both the presence of a
KAT enzyme (p300) as well as lactoyl-CoA, consistent with
enzymatic acyl-transfer of the lactate group from the acyl-
CoA to histones. Since lactate concentrations can shift from
less than 1 mM to greater than 20 mM across both normal
and pathological processes [6], a biochemical link between lac-
tate and histone modifications would be of interest in fields
ranging from exercise physiology to cancer metabolism.
While microbial lactoyl-CoA production has been
engineered in bio-industrial applications [7], the existence
or quantification of lactoyl-CoA (also called lactyl-CoA and
2-hydroxypropanoyl-CoA) in mammalian cells or tissues
has not been previously reported in the literature. Further-
more, the recent discovery of a parallel route to lysine
lactoylaton via non-enzymatic acyl-transfer from lactoyl-
glutathione raises the question as to whether these two
pathways play distinct or similar roles [8]. Since there is no
described lactoyl-CoA synthetase or transferase that activates
lactate to lactoyl-CoA in mammalian biochemistry, the in vitro
and in vivo role of lactoyl-CoA remains poorly described.
In order to better understand the potential role of enzyme-
catalysed lysine lactoylation in metazoans, here we report a
method for the detection of lactoyl-CoA by liquid chromato-
graphy–high-resolution mass spectrometry (LC-HRMS).
Fortuitously, we find that lactoyl-CoA derivatives containing
13C3
15N1-pantothenate are formed in human cells during
stable isotope labelling by essential nutrients in cell culture
(SILEC), providing access to an isotopically labelled internal
standard for quantitative studies [9]. Applying this approach
enables a comparative analysis of lactoyl-CoA and other
metabolic acyl-CoAs, providing some initial insights into
the concentration of this metabolite. By enabling the detection
and quantitative analysis of lactoyl-CoA, our study provides
the fundamental underpinnings for understanding the
function of this metabolite in biology and disease.
2. Methods
2.1. Chemicals and reagents
5-sulfosalicylic acid (SSA), trichloroacetic acid and ammonium
acetate were purchased from Sigma-Aldrich (St Louis, MO).
Optima LC-MS grade methanol (MeOH), acetonitrile (ACN),
formic acid and water were purchased from Fisher Scientific
(Pittsburgh, PA). 13C6
15N2-pantothenate calcium salt was
purchased from Isosciences (Ambler, PA).
2.2. Synthesis of L-lactoyl-coenzyme
Synthesis was conducted as previously described with minor
modifications [7]. Briefly, L-lactic acid (90 mg, 1.0 mmol) and
N-hydroxy succimide (NHS) were dissolved in anhydrous
tetrahydrofuran (THF, 8 ml). A solution of dicyclohexylcarbo-
diimide (206 mg, 1.0 mmol) in THF (20 μl) was added
dropwise to the L-lactic acid solution at 22°C with stirring.
The reaction mixture was stirred overnight at 22°C. The
resulting precipitate was removed by vacuum filtration and
the filtrate was condensed under reduced pressure to yield
L-lactyl-NHS which was used without further purification.
A solution of L-lactyL-NHS (9.3 mg, 50 mmol) in methanol
(0.5 ml) was added to a solution of coenzyme A (25 mg,
33 mmol) in aqueous bicarbonate solution (0.5 ml, 500 mM, pH
8) and stirred at 22°C for 3 h. The remaining aqueous solution
was neutralized with trifluoroacetic acid (TFA, 20 ml) and
immediately purified by C18-reversed-phase-silica chromato-
graphy. Method: (solvents—A: 0.05% TFA in water, B:
acetonitrile) gradient—0–2 column volumes (CV), 0% B; 2–12
CV, 0–50% B; 12–13 CV, 50–100% B; and 13–25 CV, 100%
B. Fractions containing the desired product were pooled and
lyophilized to provide a fluffywhite powder (7.3 mg, 26%yield).
2.3. Biosynthetic production of 13C3
15N1-acyl-coenzyme
libraries
To produce stable isotope labelled acyl-CoAs as internal
standards, we used stable isotope labelling by essential
nutrients in cell culture (SILEC) in either mammalian cell cul-
ture systems [9] or S. cerevisiae [10]. In both cases, 13C3
15N1-
pantothenate (as 13C6
15N2-pantothenate calcium salt) replaced
unlabelled pantothenate in cell culture media over sufficient
generations to incorporate into the pantothenate-derived
moiety within CoA to achieve greater than 99.5% labelling.
For some less abundant acyl-CoAs, the addition of the free
carboxylic acid was necessary to produce the labelled acyl-
CoA [11]. The labelled cells were harvested in 10% (w/v)
trichloroacetic acid for short-chain acyl-CoA or flash frozen
as a cell pellet for full acyl-chain length extraction and the
procedure for this biosynthetic production and use is detailed
elsewhere in a full protocol [12].
2.4. Liquid chromatography-high-resolution mass
spectrometry
Acyl-CoAs were quantified by LC-HRMS as previously
published [10,13]. For quantification from cells, media was
aspirated from attached cells, 1 ml of ice-cold 10% (w/v) tri-
chloroacetic acid (Sigma-Aldrich) in water was added, and
cells were scraped and transferred to 1.5 ml Eppendorf tubes.
Samples were spiked with 50 µl internal standard prepared
as previously published [10] sonicated for 12 × 0.5 s pulses in,
then protein was pelleted by centrifugation at 17 000g from
10 min at 4°C. The cleared supernatant was purified by solid-
phase extraction using Oasis HLB 1cc (30 mg) SPE columns
(Waters). Columns were washed with 1 ml methanol, equili-
brated with 1 ml water, loaded with the sample, desalted
with 1 ml water and eluted with 1 ml methanol containing
royalsocietypublishing.org/journal/rsob
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25 mM ammonium acetate. Samples were also extracted by
addition of 1 ml −80°C 80 : 20 methanol : water, followed by
sonication and centrifugation as above then evaporation of
the supernatant. A retrospective analysis was also conducted
on tissue samples using the extraction method of Minkler
et al. [14] modified for isotope dilution LC-MS [10]. Calibration
curves were prepared using analytical standards from Sigma-
Aldrich (for all acyl-CoAs other than lactoyl-CoA) and
processed identically to the samples.
The purified extracts were evaporated to dryness under
nitrogen then suspended in 55 µl 5% (w/v) 5-sulfosalicylic
acid in optima HPLC grade water. Five microlitres of samples
in 5% SSA were analysed by injection of an Ultimate 3000
HPLC coupled to a Q Exactive Plus (Thermo Scientific) mass
spectrometer in positive ESI mode using the settings described
previously [13], or for the full acyl-length extraction [11].
Modifications were made to these methods for MS/HRMS
experiments as described in each experiment for the acquisition
of precursor and product ions. Data were integrated using
XCalibur Quan and Qual Browsers (Thermo Scientific), Trace-
finder v. 4.1 (Thermo Scientific) software, and additional
statistical analysis conducted by Prism v. 7.05 (GraphPad).
2.5. Cell culture
Cells were passaged every 2–3 days at 80% confluence. Human
hepatocellular carcinoma (HepG2) cells were used at less than
20 passages from ATCC stocks (ATCC) and were cultured in
high-glucose DMEM (Thermo-Fisher Scientific), supplemented
with 10% fetal bovine serum (Gemini Biosciences) and penicil-
lin/streptomycin (Thermo-Fisher Scientific). All cells were
tested mycoplasma-free.
2.6. Heart and muscle tissue analysis
Experiments were performed on 11- to 13-week-old male and
female C57BL/6 J mice. Mice were maintained on a 12–12 h
light–dark cycle (lights on: 7:00 to 19:00) and ad libitum fed
a standard diet (LabDiet 5001, Purina). Fasted mice were
fasted overnight (19:00 to 9:00). Whole heart samples were
always harvested in the morning, snap frozen and stored at
−80°C.
3. Results
3.1. Synthesis of lactoyl-coenzyme
To define detection and identification of lactoyl-CoA we syn-
thesized a pure standard. The resulting product was a white
crystalline solid. Both NMR and LC-HRMS of the pure stan-
dard provided evidence of the structure of lactoyl-CoA
(figure 1). 1H NMR (500 MHz, D2O) δ 8.56 (d, J = 5.7 Hz,
1H), 8.35 (s, 1H), 6.13 (d, J = 5.2 Hz, 1H), 4.81 (s, 2H), 4.52
(s, 1H), 4.29 (q, J = 7.0 Hz, 1H), 4.19 (s, 2H), 3.94 (s, 1H),
3.79 (d, J = 9.3 Hz, 1H), 3.54 (d, J = 9.2 Hz, 1H), 3.37 (t, J =
6.7 Hz, 2H), 3.26 (t, J = 6.5 Hz, 2H), 2.35 (t, J = 6.7 Hz, 2H),
1.26 (d, J = 7.0 Hz, 3H), 0.86 (s, 3H), 0.74 (s, 3H). For
HRMS, we observed an intense [MH]+ ion (m/z = 840.1435)
matching the theoretical m/z calculated for C24H41N7O18P3S+
(840.1436138) (Δppm=−0.135). Based on previous literature
of the stability of acyl-CoAs in acid and lowered temperature
avoiding excessive freeze–thaw cycles [10], we re-suspended
the product in 10% TCA in water at 1 mg ml−1 to generate
aliquots of concentrated stocks for future use.
3.2. Qualitative characterization of lactoyl-CoA in cells
and tissues
Using LC-HRMS and LC-MS/HRMS, we detected lactoyl-
CoA from cells. The cell derived lactoyl-CoA matched the
synthetic standard on retention time, HRMS and MS/
HRMS on major product ions (figure 2). By contrast, the
extraction of acyl-CoAs from a different 10 cm plate of cells
with protein precipitation by −80°C 80:20 methanol : water
did not yield a discernable peak above noise (data not
shown). The retention time of the putative lactoyl-CoA (tr =
8.8 min) in reversed-phase chromatography fell earlier than
propionyl-CoA (tr = 9.2) corresponding to the additional
hydroxyl group in the acyl-group.
Since acyl-CoAs produce a wide variety of product ions
upon collision-induced dissociation, we examined the likely
specificity of each major product ion via plotting chromato-
grams for the top four ions derived from lactoyl-CoA
(figure 2). Within cells, the product ion corresponding to
the M-507 (M-506.99575) neutral loss (m/z 333.14786) was
the most intense and specific.
Based on the reanalysis of data from samples previously
acquired by LC-HRMS, we examined the detection of lac-
toyl-CoA in other cellular and tissue contexts. Since our
routine methods of acyl-CoA analysis include a full scan
acquisition covering the [MH]+ ion, we predominantly
detected from the synthetic standard, this allowed semi-
quantitative retrospective analysis of previously acquired
data. Additional experiments using a mixed chain length
acyl-CoA extraction from Minkler et al. [14] similarly detected
a LC-HRMS and LC-MS/HRMS peak corresponding to lac-
toyl-CoA from heart and muscle samples previously
acquired, which we then matched to a standard acquired
with the same chromatographic method (figure 3).
From previous stable isotope labelling using essential
nutrients in cell culture where acyl-CoA libraries incorporat-
ing 13C3
15N1-pantothenate at high efficiency (greater than
99.5%) were generated and spiked into samples, we interro-
gated generation and co-elution of 13C3
15N1-labelled lactoyl-
CoA with unlabelled lactoyl-CoA (figure 3). Previous studies
using pantothenate SILEC in HepG2 cells demonstrated co-
elution of lactoyl-Coa with 13C3
15N1-labelled lactoyl-CoA.
However, we found unfortunately that the production of
acyl-CoA internal standards by yeast SILEC in the conditions
we commonly used did not produce detectable amounts of
13C3
15N1-labelled lactoyl-CoA. This lack of
13C3
15N1-lactoyl-
CoA in these samples strongly suggests that there is no
post-extraction acyl-transfer of lactate to CoASH, as the
SILEC standard includes 13C3
15N1-CoASH that would have
artificially formed 13C3
15N1-lactoyl-CoA if possible.
3.2. Partial re-validation of a quantitative method to
include lactoyl-coenzyme
Extending previously published quantitative methodology for
acyl-CoA quantification for short- and longer chain acyl-CoAs
[13], we partially revalidated the LC-HRMS method for select
quantitative properties of lactoyl-CoA. The linear range was
estimated for isotope dilution and label-free quantification.
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200187
3
In both cases, lactoyl-CoAwas linear (R2 > 0.998) and observed
values within 25% of expected values from 0.03 pmol per
sample (3 fmol on column) to the highest range tested at
500 pmol per sample (50 fmol on column). Lactoyl-CoA was
detectable down to 0.002 pmol per sample (0.2 fmol on
column), but quantification was unstable across runs over
24 h. Re-injection of samples from both purified standards,
and purified standards spiked into cellular extract were
stable (±5%) over 24 h in a chilled autosampler. Unfortunately,
as noted, our method of producing internal standards in yeast
did not generate a lactoyl-CoA under the conditions we used.
Thus, we investigated using surrogate internal standards
including 13C3
15N1-acetyl-,
13C3
15N1-succinyl- and
13C3
15N1-
HMG-CoA. All produced linear calibration curves with high
R2 values (greater than 0.998) when plotting the ratios of
analyte/each internal standard as the dependent variable
and similar deviation of calibration points from observed
versus expected values.
3.3. Lactoyl-coenzyme is in low abundance relative to
other commonly quantified short-chain acyl-CoAs
We quantified lactoyl-CoAvia relative response factor to other
short-chain acyl-CoAs for retrospective sample analysis. This
allowed us to rank the molar amount of lactoyl-CoA versus
other acyl-CoAs detected in cells. We calculated proportional-
ity constants using known amounts of lactoyl-CoA across a
calibration curve of serial dilutions of cell and tissue relevant
concentrations of other short-chain acyl-CoAs. Proportionality
constants on a molar basis were calculated as
k ¼ [AUC(lactoyl-CoA)=pmol(lactoyl-CoA)]
[AUC(acyl-CoA)=pmol(acyl-CoA)]
:
Propionyl-CoA and succinyl-CoA had the response factors that
most closely approximated 1, where the same molar amount
of lactoyl-CoA and other acyl-CoAs generated the same
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Figure 1. (a) Structure of lactoyl-CoA (stereochemistry not shown). (b) LC-HRMS of synthetic lactoyl-CoA. (c) LC-MS/HRMS of lactoyl-CoA.
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200187
4
intensity of signal. Thus, we used propionyl-CoA as a surro-
gate to retrospectively estimate lactoyl-CoA concentrations in
a semi-quantitative manner. We found that lacotyl-CoA in
HepG2 cells was quantifiable at 0.011 pmol 10−6 cells, compar-
able to crontonyl-CoA (0.033 pmol 10−6 cells), but markedly
less abundant (30–250 times lower) than major acyl-CoAs
such as acetyl-, succinyl- and propionyl-CoA (table 1).
Since we could also detect lactoyl-CoA in tissues, we
performed the same semi-quantitative estimation in heart
tissue from mice. In these experiments, since we did not have
13C3
15N1-lactoyl-CoA due to the method of production of the
internal standard, we also used 13C3
15N1-propionyl-CoA as a
surrogate internal standard based on the similarity in response
generated from equimolar amounts found above. We com-
pared the lactoyl-CoA concentration of murine heart by sex
and by fed/fasted status. Across 25 mouse samples of
murine heart, we retrospectively estimated a mean (standard
deviation) of 0.0179 (0.0153) pmol mg−1 tissue wet weight.
We could detect no difference between fasted (0.0187 pmol
mg−1) or fed (0.0172 pmol mg−1). Similarly, we found no differ-
ence between lactoyl-CoA content in hearts from male (0.0214
(0.0173) pmol mg−1) and female (0.0145 (0.0119) pmol mg−1)
mice in this experiment. In these same tissues, acetyl-
CoA was 5.77 (3.08) pmol mg−1 and propionyl-CoA 0.476
(0.224) pmol mg−1. Thus, again we found lactoyl-CoA to be
335 (versus acetyl-) and 27 (versus propionyl-) times lower
than major short-chain acyl-CoAs, but still detectable.
4. Discussion
Increasingly sensitive proteomics approaches discover and
describe a large abundance of protein PTMs. These PTMs are
commonly putatively attributed to acyl-transfer from various
metabolites including biologically activated or reactive metab-
olite classes including acyl-CoA thioesters [1]. Due to the
shared physiochemical properties of these classes of metab-
olites, methods of purification, separation and analysis for
certain members of these classes of metabolites tend to also
capture other members of the same metabolite family. This
becomes increasingly evident with methods of detection
including HRMS that can use less restrictive analyte detection.
This leads to a rise of a combination of targeted and untargeted
metabolomics, termed hybrid metabolomics where a limited
targeted set of analytes is profiled, but metabolomics level
interrogation on the background data can still be performed
[15]. As we demonstrate here, the re-interrogation of pre-
viously acquired background metabolomics data can be
useful for metabolite discovery and semi-quantification. This
was especially useful because our approach to internal stan-
dardization using the SILEC approach, generated a library of
stable isotope labelled internal standards that fortuitously
included 13C3
15N1-lactoyl-CoA. Other approaches to internal
standard production from isotope labelled biological sources
may also show this same benefit [16]. However, the yeast-
based method of SILEC production used here did not produce
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Figure 2. (a) LC-HRMS of lactoyl-CoA from HepG2 cell extract and (b) LC-MS/HRMS of synthetic lactoyl-CoA (left) and the same ions in cell extract (right).
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detectable 13C3
15N1-lactoyl-CoA which is unfortunate for
quantification purposes but does indicate that acyl-transfer
post-extraction did not result in an artefactual lactoyl-CoA
generation. Such an artefact is certainly not unprecedented, as
acyl-groups are known to migrate to and from CoASH, and
transacylation of carboxyclic acid-containing acyl groups is bio-
logically and pharmacologically common [17].
Our data do suggest that lactoyl-CoAgeneration is relatively
less abundant than other acyl-CoAs. This is unsurprising as his-
tone lysine lactoylation was reported in conditions including
hypoxia and M1 macrophage polarization where lactate pro-
duction is high [5]. Thus, there is likely a precedent for contexts
where lacotyl-CoA would be more abundant. The quantitative
comparison to crontonyl-CoA, which is also thought to be the
acyl-donor for histone crontoylation, may put these modifi-
cations in the same realm of biological plausibility [18].
However, our retrospective analysis did not detect high levels
of lactoyl-CoA in conditionswherewe expected it. This included
cell culture within incubation of exogenous lactate in T-cell cul-
ture (data not shown). The reasons for this discrepancy across
detection require systematic investigation in the future. Similarly,
investigations of the comprehensive changes of other acyl-CoAs
(including CoASH) that could competewith lactoyl-CoA for the
formation of acyl-transfer to lysine would be warranted.
This study has two important limitations that warrant dis-
cussion. First, although the description of lyisine lactoylation
was the reason we synthesized then searched for lactoyl-CoA
this study does not quantify either lactoyl-lysine or lacotyl-
GSH. Future studies will be needed to compare the relative
concentrations of each of these acylated molecules and the
biological contexts where they may be important. As noted
recently by Kulkarni and Brookes, Kla would be isobaric to
N6-carboxyethyl lysine resulting frommethyglyoxal, a reactive
side-product of glucose metabolism [19]. Thus, future studies
must resolve these potentially interfering species via isotope
tracing or detection methods capable of discerning the two
lysine modifications. Second, our methods were operating
near their estimated limits of detection for lactoyl-CoA which
poses problems of censoring and imposes limits on experimen-
tal design. Further improvements in analysis, including more
sensitive LC-MS approaches reaching atto- and zepto-mole
on column quantification may be needed considering the low
abundance of lactoyl-CoA. Increased sensitivity would be
especially necessary for isotopic tracing applications where
additional sensitivity is required since labelling distributes
signal intensity across isotopologues. Such isotope tracing
experiments from labelled glucose, pyruvate and lactate
would be one of the most straightforward ways of establishing
the route and mechanism of lactoyl-lysine formation and are
tractable even in human studies [20]. Additionally, future
methods could achieve separation of enantiomeric acyl-CoAs,
including lactoyl-CoA (which could form from D- or L-lactic
acid). These analytical improvements would be useful in
the next steps of elucidating the as yet unknown biological
function, enzymology and occurrence of lactoyl-CoA.
The biological implication of acyl-donors is that they can
serve as a nutrient responsive sensor, especially when the acyla-
tion is a modification of histones that results in a functional
change on transcription (or other processes involving histones)
[1]. Ongoingwork has implicatedhigher abundance acyl-CoAs,
especially acetyl-CoA, in nutrient response. Notably, even the
less abundant crotonyl-CoA that was the closest comparator
in this study has similarly been implicated in transcriptional
changes resulting from crontonylation of histones [18] and
cellular effects in vivo with microbiota-dependent metabolite
changes [21]. In the casewhere the acylations are enzymatically
generated, lower abundance acyl-donating substrates may be
limiting rather than the acyl-transferase enzymes. For non-
enzymatically generated acylations, the substrate concentration
and reactivitymay be themost important driver of the acylation
[2]. This poses a particular difficulty in finding, and then
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Figure 3. Detection of lactoyl-CoA from retrospective analysis (a) of tissues
by LC-HRMS (top) and LC-MS/HRMS (bottom) and (b) co-elution of lactoyl-
CoA with 13C3
15N1-lactoyl-CoA from retrospective data.
Table 1. Concentrations of short-chain acyl-CoAs within HepG2 cells.
acyl-CoA pmol/106 cells standard deviation
acetyl-CoA 10.644 1.364
succinyl-CoA 25.467 2.818
propionyl-CoA 3.532 0.652
CoASH 1.734 0.189
butyryl-CoA 1.013 0.159
HMG-CoA 0.971 0.326
glutaryl-CoA 0.647 0.112
valeryl-CoA 1.118 0.143
crotonoyl-CoA 0.032 0.015
lactoyl-CoA 0.011 0.003
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quantifying, those low abundance substrates. Alternatively, it
has been proposed that the channelled or highly compartmen-
talized nature of some reactions involving moving acyl groups
makes their concentration measurement at a whole-cell level
less relevant to the underlying biology [22–24]. Thus, future
work should also examine the concentration dependence
and potential for compartmentalization and channelling
of reactions using lactoyl-CoA. The ability to quantify this
metabolite will enable these studies.
5. Conclusion
We can detect and quantify lactoyl-CoAwithin cells and tissues
at low pmol abundance. This should be valuable for future
studies interrogating the role of lactoyl-CoAand itsmechanisms
ofproduction andusewithinwider biologic contexts. Theutility
of LC-HRMS data for retrospective reanalysis to examine newly
describedmetabolites also highlights thepowerof this approach
over more targeted acquisition strategies.
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